Tuesday, April 27, 2010

New medical device approved for asthma: Alair Bronchial Thermoplasty System by Asthmatx

We've seen several new drugs get approved for asthma, but now we have a medical device as an option.
The U.S. Food and Drug Administration today approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in certain adults.

The Alair Bronchial Thermoplasty System is intended for patients ages 18 and older whose severe and persistent asthma is not well-controlled with inhaled corticosteroids and long-acting beta agonist medications.
The FDA is requiring a five-year post-approval study of the device to study its long-term safety and effectiveness. The device manufacturer, Asthmatx, will follow many of the patients who were enrolled in the clinical trial and enroll 300 new patients at several medical centers across the United States.
To learn more about this FDA approval, click here.
To learn about the system, click here.

No comments:

Post a Comment

Blog Widget by LinkWithin